Home › Pulmonary Embolism › NCT05050617
Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Age \>= 18 years of age * ED diagnosis of acute pulmonary embolism with identification on CT imaging Exclusion Criteria: * Age \<18 years of age * Inability to provide informed consent * Incarceration * Current PE previously diagnosed prior to index ED visit
About the study
This study is an observational, prospective study examining the role point-of-care echocardiography of predicting short term adverse outcomes in emergency department patients with acute pulmonary embolism.
The primary objective is to assess the diagnostic performance of ultrasound-guided measures of right ventricular dilation (RVD) and strain in predicting clinical outcomes in acute PE.
The secondary objective is to investigate the utility of combining ultrasound-guided measures of RVD and the pulmonary embolism severity index (PESI) score in predicting adverse outcomes in acute PE.
What is being tested
- Point-of-care echocardiography (diagnostic test)
Sponsor: WellSpan Health · Participants: 250 · Started: Sep 9, 2021
Contact the study team
- Brent A Becker, MD · Phone: 717 851 4819
- Kristen Oliff, BS · Phone: 717 851 4104
Official record on ClinicalTrials.gov — NCT05050617
Locations in the U.S.
| Pennsylvania | Wellspan York Hospital, York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.